AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference

Audio By Carbonatix

LATHAM, N.Y.--(BUSINESS WIRE)--Aug 6, 2025--

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity 45 th Annual Growth Conference at 9:00 a.m. ET on Tuesday, August 12, 2025.

A live webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250806902319/en/

CONTACT: Investors:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: ONCOLOGY MEDICAL DEVICES HEALTH HEALTH TECHNOLOGY CLINICAL TRIALS CARDIOLOGY

SOURCE: AngioDynamics, Inc.

Copyright Business Wire 2025.

PUB: 08/06/2025 04:30 PM/DISC: 08/06/2025 04:30 PM

http://www.businesswire.com/news/home/20250806902319/en